Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer

Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer

US Patent 11090266 · Granted Aug 17, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EGFL6 specific monoclonal antibodies and methods of their use2024
DNA aptamers and use thereof for the treatment of cancer2024
Dual assembly nanoparticles2020
EGFL6 specific monoclonal antibodies and methods of their use2020
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant o2020
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant o2020
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant o2020
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant o2018
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant o2018
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant o2018
Bioreactor vessel for large scale growing of plants under aseptic condition2018
Axial and circumferential flaw sensing eddy current probe2016